Insulin analogs with enhanced zinc binding


Ontology type: sgo:Patent     


Patent Info

DATE

N/A

AUTHORS

Johann Ertl , Paul Habermann , Karl Geisen , Gerhard Seipke , Axel Wollmer

ABSTRACT

The invention relates to insulin analogs exhibiting enhanced zinc binding capacity and to stable zinc complexes thereof having a retarded activity in comparison with human insulin. The invention further relates to a method for the production of said insulin analogs and to their use, particularly in pharmaceutical preparations for therapy of type I and type II diabetes mellitus. More... »

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/3053", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "name": "Johann Ertl", 
        "type": "Person"
      }, 
      {
        "name": "Paul Habermann", 
        "type": "Person"
      }, 
      {
        "name": "Karl Geisen", 
        "type": "Person"
      }, 
      {
        "name": "Gerhard Seipke", 
        "type": "Person"
      }, 
      {
        "name": "Axel Wollmer", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/188721a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009916757", 
          "https://doi.org/10.1038/188721a0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1073/pnas.81.22.7093", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030439312"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1432-1033.1989.tb15245.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051817753"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1021/jm00148a025", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1055936741"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/diacare.13.9.923", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1070745239"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "description": "

The invention relates to insulin analogs exhibiting enhanced zinc binding capacity and to stable zinc complexes thereof having a retarded activity in comparison with human insulin. The invention further relates to a method for the production of said insulin analogs and to their use, particularly in pharmaceutical preparations for therapy of type I and type II diabetes mellitus.

", "id": "sg:patent.US-6686177-B1", "keywords": [ "insulin analog", "zinc binding", "invention", "binding capacity", "complex", "comparison", "human insulin", "method", "Pharmaceutical Preparation", "therapy", "Type 2 Diabetes Mellitus" ], "name": "Insulin analogs with enhanced zinc binding", "recipient": [ { "id": "https://www.grid.ac/institutes/grid.417555.7", "type": "Organization" }, { "id": "https://www.grid.ac/institutes/grid.420214.1", "type": "Organization" } ], "sameAs": [ "https://app.dimensions.ai/details/patent/US-6686177-B1" ], "sdDataset": "patents", "sdDatePublished": "2019-03-07T15:32", "sdLicense": "https://scigraph.springernature.com/explorer/license/", "sdPublisher": { "name": "Springer Nature - SN SciGraph project", "type": "Organization" }, "sdSource": "s3://com.uberresearch.data.dev.patents-pipeline/full_run_10/sn-export/5eb3e5a348d7f117b22cc85fb0b02730/0000100128-0000348334/json_export_2d2c25e7.jsonl", "type": "Patent" } ]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/patent.US-6686177-B1'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/patent.US-6686177-B1'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/patent.US-6686177-B1'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/patent.US-6686177-B1'


 

This table displays all metadata directly associated to this object as RDF triples.

66 TRIPLES      14 PREDICATES      30 URIs      18 LITERALS      2 BLANK NODES

Subject Predicate Object
1 sg:patent.US-6686177-B1 schema:about anzsrc-for:3053
2 schema:author N0ae5cfa9af9b4e04afe02b18d322ab04
3 schema:citation sg:pub.10.1038/188721a0
4 https://doi.org/10.1021/jm00148a025
5 https://doi.org/10.1073/pnas.81.22.7093
6 https://doi.org/10.1111/j.1432-1033.1989.tb15245.x
7 https://doi.org/10.2337/diacare.13.9.923
8 schema:description <p>The invention relates to insulin analogs exhibiting enhanced zinc binding capacity and to stable zinc complexes thereof having a retarded activity in comparison with human insulin. The invention further relates to a method for the production of said insulin analogs and to their use, particularly in pharmaceutical preparations for therapy of type I and type II diabetes mellitus.</p>
9 schema:keywords Pharmaceutical Preparation
10 Type 2 Diabetes Mellitus
11 binding capacity
12 comparison
13 complex
14 human insulin
15 insulin analog
16 invention
17 method
18 therapy
19 zinc binding
20 schema:name Insulin analogs with enhanced zinc binding
21 schema:recipient https://www.grid.ac/institutes/grid.417555.7
22 https://www.grid.ac/institutes/grid.420214.1
23 schema:sameAs https://app.dimensions.ai/details/patent/US-6686177-B1
24 schema:sdDatePublished 2019-03-07T15:32
25 schema:sdLicense https://scigraph.springernature.com/explorer/license/
26 schema:sdPublisher N5e5de40407a7418fb25e27141c322a28
27 sgo:license sg:explorer/license/
28 sgo:sdDataset patents
29 rdf:type sgo:Patent
30 N0ae5cfa9af9b4e04afe02b18d322ab04 rdf:first N1280255ea7cd4266b91f6e25d2f1dee2
31 rdf:rest Nb2c1d05548ff4db68b8a912496bd17d3
32 N1280255ea7cd4266b91f6e25d2f1dee2 schema:name Johann Ertl
33 rdf:type schema:Person
34 N339acfb0ae9e465da8de77fc285fca4e schema:name Karl Geisen
35 rdf:type schema:Person
36 N50a7209f2e664e958445a73132811d72 rdf:first N339acfb0ae9e465da8de77fc285fca4e
37 rdf:rest Nae12ab67d4d149959a5a16b73b80f027
38 N5e5de40407a7418fb25e27141c322a28 schema:name Springer Nature - SN SciGraph project
39 rdf:type schema:Organization
40 N6c79e21d9d714130b4598e241f843ac2 schema:name Axel Wollmer
41 rdf:type schema:Person
42 Nae12ab67d4d149959a5a16b73b80f027 rdf:first Nf2605649d39f4e5985fcdb269ab23a8b
43 rdf:rest Ne6fee6c7638e4faf9e0061d8fbdf4348
44 Nb2c1d05548ff4db68b8a912496bd17d3 rdf:first Nb9c9ed76e03e489294402340890dd20c
45 rdf:rest N50a7209f2e664e958445a73132811d72
46 Nb9c9ed76e03e489294402340890dd20c schema:name Paul Habermann
47 rdf:type schema:Person
48 Ne6fee6c7638e4faf9e0061d8fbdf4348 rdf:first N6c79e21d9d714130b4598e241f843ac2
49 rdf:rest rdf:nil
50 Nf2605649d39f4e5985fcdb269ab23a8b schema:name Gerhard Seipke
51 rdf:type schema:Person
52 anzsrc-for:3053 schema:inDefinedTermSet anzsrc-for:
53 rdf:type schema:DefinedTerm
54 sg:pub.10.1038/188721a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009916757
55 https://doi.org/10.1038/188721a0
56 rdf:type schema:CreativeWork
57 https://doi.org/10.1021/jm00148a025 schema:sameAs https://app.dimensions.ai/details/publication/pub.1055936741
58 rdf:type schema:CreativeWork
59 https://doi.org/10.1073/pnas.81.22.7093 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030439312
60 rdf:type schema:CreativeWork
61 https://doi.org/10.1111/j.1432-1033.1989.tb15245.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1051817753
62 rdf:type schema:CreativeWork
63 https://doi.org/10.2337/diacare.13.9.923 schema:sameAs https://app.dimensions.ai/details/publication/pub.1070745239
64 rdf:type schema:CreativeWork
65 https://www.grid.ac/institutes/grid.417555.7 schema:Organization
66 https://www.grid.ac/institutes/grid.420214.1 schema:Organization
 




Preview window. Press ESC to close (or click here)


...